Hepatic STAT1-Nuclear Translocation and Interleukin 28B Polymorphisms Predict Treatment Outcomes in Hepatitis C Virus Genotype 1-Infected Patients
Tatsuo Miyamura(National Institute of Infectious Diseases), Osamu Yokosuka(Chiba University)
Cited by 26
Related Papers
Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma
|International Journal of Cancer|2014|117
New antiviral therapies for chronic hepatitis C
|Hepatology International|2010|105
Hepatitis C Virus Core Protein Activates Erk and P38 Mapk in Cooperation With Ethanol in Transgenic Mice
|Hepatology|2003|99